Biotechnology
RhyGaze AG is a cutting-edge biotechnology company based in Basel, Switzerland, focused on developing gene therapies for retinal diseases causing blindness. Founded on pioneering research from the Institute of Molecular and Clinical Ophthalmology Basel, RhyGaze aims to restore vision and transform the lives of patients worldwide.